A Phase 3 Veliparib plus Chemotherapy Study in Adv/Met squamous NSCLC

• Research type

  Research Study

• Full title

  Randomized, Double-Blind, Multicenter, Phase 3 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

• IRAS ID

  150889

• Contact name

  Lal Rohit

• Contact email

  rohit.lal@gstt.nhs.uk

• Sponsor organisation

  AbbVie Ltd.

• Eudract number

  2013-005020-42

• REC name

  South West - Central Bristol Research Ethics Committee

• REC reference

  14/SW/0091

• Date of REC Opinion

  2 Jun 2014

• REC opinion

  Further Information Favourable Opinion